BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11827424)

  • 1. Synvisc perisynovitis.
    Zardawi IM; Chan I
    Pathology; 2001 Nov; 33(4):519-20. PubMed ID: 11827424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee.
    Zardawi IM
    J Bone Joint Surg Am; 2003 Dec; 85(12):2484; author reply 2484-5. PubMed ID: 14668528
    [No Abstract]   [Full Text] [Related]  

  • 3. Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee : a report of six cases.
    Chen AL; Desai P; Adler EM; Di Cesare PE
    J Bone Joint Surg Am; 2002 Jul; 84(7):1142-7. PubMed ID: 12107313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased frequency of acute local reaction to intra-articular Hylan G-F 20 (Synvisc) in patients receiving more than one course of treatment.
    Morton AH; Shannon P
    J Bone Joint Surg Am; 2003 Oct; 85(10):2050; author reply 2050-1. PubMed ID: 14563817
    [No Abstract]   [Full Text] [Related]  

  • 5. Granulomatous synovitis after intraarticular Hylan GF-20. A report of two cases.
    Michou L; Job-Deslandre C; de Pinieux G; Kahan A
    Joint Bone Spine; 2004 Sep; 71(5):438-40. PubMed ID: 15474399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral symmetric inflammatory reaction to hylan G-F 20 injection.
    Martens PB
    Arthritis Rheum; 2001 Apr; 44(4):978-9. PubMed ID: 11315938
    [No Abstract]   [Full Text] [Related]  

  • 7. Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee.
    Marino AA; Dunn S; Waddell DD
    J Bone Joint Surg Am; 2003 Oct; 85(10):2051-2; author reply 2052-3. PubMed ID: 14563818
    [No Abstract]   [Full Text] [Related]  

  • 8. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice.
    Kemper F; Gebhardt U; Meng T; Murray C
    Curr Med Res Opin; 2005 Aug; 21(8):1261-9. PubMed ID: 16083536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Single Intra-Articular Injection of Novel Hyaluronan (HYA-JOINT Plus) with Synvisc-One for Knee Osteoarthritis: A Randomized, Controlled, Double-Blind Trial of Efficacy and Safety.
    Sun SF; Hsu CW; Lin HS; Liou IH; Chen YH; Hung CL
    J Bone Joint Surg Am; 2017 Mar; 99(6):462-471. PubMed ID: 28291178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of an acute attack of calcium pyrophosphate dihydrate arthritis by intra-articular injection of hylan G-F 20 (Synvisc).
    Kroesen S; Schmid W; Theiler R
    Clin Rheumatol; 2000; 19(2):147-9. PubMed ID: 10791628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute adverse reaction to hylan G-F 20: comment on the article by Martens.
    Tomás Gil J; Lopez Mateu P; Alegre J
    Arthritis Rheum; 2003 Mar; 48(3):866; author reply 866. PubMed ID: 12632457
    [No Abstract]   [Full Text] [Related]  

  • 12. Are there distinctive inflammatory flares after hylan g-f 20 intraarticular injections?
    Pullman-Mooar S; Mooar P; Sieck M; Clayburne G; Schumacher HR
    J Rheumatol; 2002 Dec; 29(12):2611-4. PubMed ID: 12465161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No conclusive evidence that histologically found granulomas and acute local reactions following hylan G-F 20 injections are related or have clinical significance.
    Waddell DD; Beyer A; Thompson TL; Morawiak J; Elkins C; Rosenberg A; Spitzer A
    J Knee Surg; 2014 Apr; 27(2):99-104. PubMed ID: 23873318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Systemic Inflammatory Polyarthritis After Zygapophyseal Joint Injection With Hylan G-F 20 (Synvisc-One).
    Kocak D; Annaswamy T; Chong S; Arora R
    Am J Phys Med Rehabil; 2018 Feb; 97(2):147-149. PubMed ID: 28708631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased frequency of acute local reaction to intra-articular hylan GF-20 (synvisc) in patients receiving more than one course of treatment.
    Leopold SS; Warme WJ; Pettis PD; Shott S
    J Bone Joint Surg Am; 2002 Sep; 84(9):1619-23. PubMed ID: 12208919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and performance of Hydros and Hydros-TA for knee osteoarthritis: a prospective, multicenter, randomized, double-blind feasibility trial.
    Petrella RJ; Emans PJ; Alleyne J; Dellaert F; Gill DP; Maroney M
    BMC Musculoskelet Disord; 2015 Mar; 16():57. PubMed ID: 25887932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hylan G-F20 and galactomannan joint flares are associated to acute synovitis and release of inflammatory cytokines.
    de Melo Nunes R; Cunha PLR; Pinto ACMD; Girão VCC; de Andrade Feitosa JP; Rocha FAC
    Adv Rheumatol; 2020 May; 60(1):26. PubMed ID: 32393335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequelae of Hylan G-F 20 viscosupplementation of the knee.
    Mont MA; Etienne G
    J Bone Joint Surg Am; 2003 May; 85(5):967-8; author reply 968-9. PubMed ID: 12728054
    [No Abstract]   [Full Text] [Related]  

  • 19. Hylan G-F 20 Versus Low Molecular Weight Hyaluronic Acids for Knee Osteoarthritis: A Meta-Analysis.
    Zhao H; Liu H; Liang X; Li Y; Wang J; Liu C
    BioDrugs; 2016 Oct; 30(5):387-396. PubMed ID: 27435213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory and immunological responses to hyaluronan preparations. Study of a murine biocompatibility model.
    Ottaviani RA; Wooley P; Song Z; Markel DC
    J Bone Joint Surg Am; 2007 Jan; 89(1):148-57. PubMed ID: 17200322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.